NIH-funded research R01 grant

Localized delivery to boost tendon-to-bone healing after ACL reconstruction

Official title: Localized small molecule delivery to improve tendon-to-bone integration following anterior cruciate ligament reconstruction

Funded at University of Pennsylvania · NIH-11361627 · Data updated 2026-11-12

A study testing a targeted small-molecule treatment to improve how the tendon graft heals at the bone after ACL reconstruction, with the goal of reducing graft failure and helping patients get back to activity.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pennsylvania
NIH-funded
Lab location1 site (Philadelphia, United States)
Project startSeptember 1, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$539,906
NIH project number5R01AR082810-03
Project IDNIH-11361627 on NIH RePORTER

Who could benefit from this research

Could help

Adults with ACL injuries undergoing reconstruction who are eligible for the study.

Less likely to help

Patients not undergoing ACL reconstruction or with contraindications to the study treatment may not benefit.

What this research studies

This project focuses on the healing process after ACL reconstruction, aiming to strengthen the tendon-bone attachment. It will use a small-molecule approach to influence the hedgehog signaling pathway, which guides the formation of the fibrocartilage zones essential for a strong enthesis. The team will evaluate how this treatment affects healing in a clinical-relevant setting and monitor functional outcomes relevant to patients’ recovery and activity levels. The goal is to shorten recovery time, reduce re-injury risk, and improve long-term knee stability.

Why it matters

Potential benefit: If successful, patients could experience stronger graft integration, fewer reinjuries, and quicker return to sports.

How similar studies have gone: Previous work suggests hedgehog signaling influences fibrocartilage formation; this study applies that concept to human ACL reconstruction, showing potential but needing confirmation.

Where this research is happening

  • University of Pennsylvania
    Philadelphia, United States
    Active

Researchers

  • Principal investigator: Dyment, Nathaniel a. — University of Pennsylvania
  • Study coordinator: Dyment, Nathaniel a.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.